Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 6 Colorectal Neoplasms 6 Breast Neoplasms 6 Neoplasms 5 Lung Neoplasms 4 Prostatic Neoplasms 2 Papillomavirus Infections 2 End Stage Liver Disease 2 Warts 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Tinea 1 Smoking 1 Skin Neoplasms 1 Nevus 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Molluscum Contagiosum 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Cancer Screening 1 Liver Neoplasms 1 Kidney Failure, Chronic 1 Keratosis, Actinic 1 Intestinal Neoplasms 1 Impetigo 1 Herpes Zoster 1 Hepatitis C 1 HIV Infections 1 Gastrointestinal Neoplasms 1

Interventions

Therapeutics 25 Psychiatric Rehabilitation 16 Cognitive Behavioral Therapy 10 Early Intervention, Educational 9 Methods 7 Yoga 6 Mindfulness-Based Cognitive Therapy 6 Esketamine 5 Educational Status 5 Surveys and Questionnaires 4 Saline Solution 4 Psychosocial Intervention 4 Mindfulness 4 Interviews as Topic 4 Counseling 4 Control Groups 4 Caregivers 4 Behavior Therapy 4 Acupuncture Therapy 4 Palliative Care 3 Meditation 3 Hypnosis 3 Exercise Therapy 3 Transcranial Magnetic Stimulation 2 Transcranial Direct Current Stimulation 2 Standard of Care 2 Self-Help Groups 2 Psychotherapy 2 Mindfulness-Based Stress Reduction 2 Massage 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Depression × Mass Screening × Clear all

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed

802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡